Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- CheckyesterdayChange DetectedAn updated site revision number is shown, changing from v3.5.3 to v3.5.4. This is a minor platform release reflected in the page metadata and does not alter the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded publication citation: Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjornevik T. Quantitative [18F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer. Mol Imaging Biol. 2026 Apr 23. Online ahead of print. Revision: v3.5.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.2 is displayed, replacing the previous v3.5.0 revision label.SummaryDifference0.1%

- Check58 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No substantive changes to the study details or content were observed.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3, reflecting a page update.SummaryDifference0.1%

- Check94 days agoChange DetectedAddition of Revision: v3.4.2 and removal of a general funding/operating status notice; prior Revision: v3.4.1 is also removed. No study details are affected.SummaryDifference0.4%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.